Esophageal embolization for hemostasis in cancer patients presenting with upper gastrointestinal bleeding in the setting of antiplatelet therapy: A case report

抗血小板治疗期间出现上消化道出血的癌症患者食管栓塞止血:病例报告

阅读:4

Abstract

Upper gastrointestinal bleeding (UGIB) is a common cause of hospitalization in older patients and carries high morbidity and mortality if not managed properly. Risk factors for developing UGIB include advanced age, Helicobacter pylori infection, medication use (NSAIDs, aspirin, P2Y12 inhibitors, anticoagulants, and steroids), and esophageal cancer, which, although less common, is an important cause in clinical practice. Hemostatic intervention is mandatory for these patients, with various methods available, including endoscopic hemostasis, transarterial embolization, and surgery. We report the case of a 75-year-old male patient on anticoagulant therapy after coronary stenting who presented with UGIB due to an esophageal tumor and underwent timely hemostatic embolization. This case highlights the role of endovascular intervention in patients with gastrointestinal bleeding who are on anticoagulant therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。